L. Reddenna

Clinical Efficacy and Safety Profile of Lurasidone Comparing with Risperidone: Randomized, Open Label, Clinical Study

V. Sreedhar, L. Reddenna, T. Rajavardhana, J. Thippe Rudra, E. Pavan Kumar, M. Pramod Kumar, M. Kalyan Sai, T. Sivasaileela, Y. Yamini, B. Sreelekha, B. Nishkala & M. Mahesh · Journal of Pharmaceutical Research International · 2021

There are diverse studies which afford evidences that risperidone is as effective as second generation antipsychotics in treating positive symptoms and more effective in treatment of negative symptoms. This study is intended to find the clinical efficacy and safety profile of lur...

Open access Research Article 10.9734/jpri/2021/v33i431167

Prescribing Pattern in Geriatrics with Cardio Vascular Diseases using Beers Criteria

E. Pavan Kumar, V. Sreedhar, P. Ramakrishna Reddy, L. Reddenna, M. Pramod Kumar, B. Jayanthi, N. Sirisha & K. Salma · Journal of Pharmaceutical Research International · 2021

Aim: Cardiovascular disease (CVD) is a major health problem throughout the world and a common cause of premature morbidity and mortality. CVD is a general category of diseases that affects the heart and the circulatory system. The main aim of the study is to assess the prescribin...

Open access Research Article 10.9734/jpri/2021/v33i531176

Obesity and Overweight in Relation to Hypertension and Associated Risk in School Children

Gorantla Naresh Babu, P. Jameela, S. Jafar Sharif, A. Ramya, K. Ziyaul Haq, Sasi Kumar, L. Reddenna & V. Sreedhar · Journal of Pharmaceutical Research International · 2021

Aim: Hypertension is a major public health problem worldwide and is associated with high mortality and morbidity. The main aim of this study is to assess obesity and overweight in school children and their relationship to hypertension and associated risk factors. Study Design: Po...

Open access Research Article 10.9734/jpri/2021/v33i431174